Finally, we examined the efficacy of S55746 in combination with either the MCL1 inhibitor UMI-77 or the HDAC inhibitor panobinostat in vivo using a DLBCL PDX mouse model (Fig. 5C and SI Appendix, Fig. S10). This evidence concerns the gene MCL1 and diffuse large B-cell lymphoma.